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Unusual early symptoms of Parkinson’s 
disease.  Why do we need to identify them?
Sintomas incomuns da fase inicial da doença de Parkinson. Por que precisamos 
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One of the most frequent situations during the diagnostic phase of Parkinson’s disease (PD) is to correctly identify symptoms which could be related to it. The current criteria to diagnose PD are based on the presence of the four classi-cal symptoms: bradykinesia, tremor, rigidity and postural abnormalities. By the 
other hand, non-classical manifestations such as subtle motor and non-motor symptoms are 
frequently seen antedating the diagnosis of PD. In this issue, Teive and colleagues report a se-
ries of fifteen PD patients with unusual signs and symptoms at the early stage of the disease1. 
This study does not have the aim to identify signs or symptoms that could predict the diagno-
sis PD or its prodromal phase but calls the attention to apparently unspecific complaints that 
could be related to bradykinesia, rigidity, fatigue and other motor and non-motor signs of PD. 
Some of the unusual characteristics of the series of Teive et al. are not so unusual and 
has already been described. We can mention color discrimination deficit, Rolex sign, shoulder 
pain and fatigue. Similar to these somewhat odd manifestations, we can list: a tendency to 
swim in circles, to write smaller and inclined usually in an upward direction, and early difficul-
ties in coordination that are reported as equipment malfunctioning2.
Color discrimination deficit is may be present in PD patients, however the pathophysiolo-
gy of it is not completely understood.  Dopaminergic deficit in the retina and cortical dysfunc-
tion associated to cognitive impairment are possible mechanisms involved. Visual symptoms 
could be present in both early and advanced phases of PD and minor hallucinations have been 
described in early stages of PD3. 
Rhinorrhea is not commonly described as classical non-motor symptom of PD. However, 
some studies have reported five-time increased prevalence of rhinorrhea in PD patients com-
pared to control4,5,6. The relation between rhinorrhea and PD is not clear since it was investi-
gated with non-validated questionnaires or tests. Moreover, it is difficult to exclude other com-
mon conditions, like rhinitis and sinusitis or collateral effect of antiparkinsonian drugs as the 
cause of the rhinorrhea.
PD phenotypes were classically divided into tremor dominant, postural instability and gait 
difficult (PIGD), or indeterminate subtype. PIGD subtype is marked by bradykinesia, rigidity, 
axial symptoms and has a higher risk for non-motor symptoms7. This could increase the prob-
ability to find out more unusual complaints in this subgroup. Non- motor symptoms gener-
ally have been described at the advanced phase of PD, but recent researches revealed that 
almost 40% of treated PD and drug naïve patients in the early phase of disease have a severe 
non-motor symptoms burden8.
We need early diagnosis of PD to provide an appropriated treatment of motor and 
non-motor symptoms, and perhaps in the future, to use a neuroprotective strategy. To ad-
dress this point, many studies in progress are focusing on pre motor or prodromal symptoms. 
Recognized prodromal markers are: REM sleep disorder, olfactory loss, constipation, excessive 
daytime somnolence, symptomatic hypotension, severe erectile dysfunction, urinary dysfunc-
tion, and depression9. These manifestations can produce subtle symptoms not yet recognized 
as complaints of the early phase of PD.  Teive et al. raised the point and now there is a need of 
systematic studies with a large number of patients looking for this unusual symptoms. An ear-
ly and precise diagnosis of PD is one of the challenges of our clinical practice.
780 Arq Neuropsiquiatr 2016;74(10):779-780
References
1. Teive HAG, Bertucci Filho DC, Munhoz R. Unusual motor and non-motor 
symptoms and signs in the early stage of Parkinson’s disease.  Arq 
Neuropsiquiatr. 2016;74(10):781-84. doi: 10.1590/0004-282X20160126
2. Lees AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet. 
2009;373(9680):2055-66. doi:10.1016/S0140-6736(09)60492-X
3. Pagonabarraga J, Martinez-Horta S, Fernández de Bobadilla R, 
Pérez J, Ribosa-Nogué R, Marín J et al. Minor hallucinations occur 
in drug-naive Parkinson’s disease patients, even from the premotor 
phase. Mov Disord. 2016;31(1):45-52. doi:10.1002/mds.26432 
4. Friedman JH, Amick MM, Chou KL. Rhinorrhea and olfaction 
in Parkinson disease. Neurology. 2008;70(6):487-9. 
doi:10.1212/01.wnl.0000279380.25130.ce 
5. Chou KL, Koeppe RA, Bohnen NI. Rhinorrhea: a common 
nondopaminergic feature of Parkinson’s disease. Mov Disord. 
2011;26(2):320-3. doi:10.1002/mds.23366
6. Kano O, Yoshioka M, Nagayama H, Hamada S, Maeda T, Hasegawa 
T et al. Young Japanese Expert Group for Parkinson’s Disease and 
Movement Disorders: YJ-EXPANDS. Rhinorrhea in Parkinson’s 
disease: a consecutive multicenter study in Japan. J Neurol Sci. 
2014;343(1-2):88-90. doi:10.1016/j.jns.2014.05.039 
7. Ba F, Obaid M, Wieler M, Camicioli R, Martin WR. Parkinson disease: 
the relationship between non-motor symptoms and motor phenotype. 
Can J Neurol Sci. 2016;43(2):261-7. doi:10.1017/cjn.2015.328 
8. Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF 
et al. Non-motor symptoms burden in treated and untreated early 
Parkinson’s disease patients: argument for non-motor subtypes. Eur 
J Neurol. 2015;22(8):1145-50. doi:10.1111/ene.12733 
9. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B et al. MDS 
research criteria for prodromal Parkinson’s disease. Mov Disord. 
2015;30(12):1600-11. doi:10.1002/mds.26431 
